Correction: Nanoencapsulated rituximab mediates superior cellular immunity against metastatic B-cell lymphoma in a complement competent humanized mouse model

Código QR

Correction: Nanoencapsulated rituximab mediates superior cellular immunity against metastatic B-cell lymphoma in a complement competent humanized mouse model

Guardado en:

Detalles Bibliográficos
Formato:	article
Lenguaje:	EN
Publicado:	BMJ Publishing Group 2021
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/364324dfd8d74444bf75578c0b025461
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Nanoencapsulated rituximab mediates superior cellular immunity against metastatic B-cell lymphoma in a complement competent humanized mouse model
por: Lan Wang, et al.
Publicado: (2021)

Rituximab in the treatment of non-Hodgkin&rsquo;s lymphoma
por: Beate Hauptrock, et al.
Publicado: (2008)

Targets of complement-fixing antibodies in protective immunity against malaria in children
por: Linda Reiling, et al.
Publicado: (2019)

Vaccine-induced, but not natural immunity, against the Streptococcal inhibitor of complement protects against invasive disease
por: Lionel K. K. Tan, et al.
Publicado: (2021)

Apoptosis-promoting effect of rituximab-conjugated magnetic nanoprobes on malignant lymphoma cells with CD20 overexpression
por: Song L, et al.
Publicado: (2019)

Antibody Targets and Properties for Complement-Fixation Against the Circumsporozoite Protein in Malaria Immunity
por: Liriye Kurtovic, et al.
Publicado: (2021)

Borrelia valaisiana resist complement-mediated killing independently of the recruitment of immune regulators and inactivation of complement components.
por: Jasmin Schwab, et al.
Publicado: (2013)

Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma
por: Cristina López, et al.
Publicado: (2019)

Nanoencapsulation as a General Solution for Lyophilization of Labile Substrates
por: Girish Vallerinteavide Mavelli, et al.
Publicado: (2021)

Nanoencapsulation of pomegranate bioactive compounds for breast cancer chemoprevention
por: Shirode AB, et al.
Publicado: (2015)

Nanoencapsulation of natural triterpenoid celastrol for prostate cancer treatment
por: Sanna V, et al.
Publicado: (2015)

Determinants of renal cell carcinoma invasion and metastatic competence
por: Kangsan Kim, et al.
Publicado: (2021)

The stability of complement-mediated bactericidal activity in human serum against Salmonella.
por: Colette M O'Shaughnessy, et al.
Publicado: (2012)

Nanoencapsulation of bioactive ingredients: trends in pharmaceutical industry and functional foods
por: Diana Margarita MÁRQUEZ FERNÁNDEZ
Publicado: (2019)

The use of nanoencapsulation to decrease human skin irritation caused by capsaicinoids
por: Contri RV, et al.
Publicado: (2014)

Increased Body Exposure to New Anti-Trypanosomal Through Nanoencapsulation
por: Renata Tupinambá Branquinho, et al.
Publicado: (2017)

The nasal delivery of nanoencapsulated statins – an approach for brain delivery
por: Clementino A, et al.
Publicado: (2016)

Nanoencapsulation of sulforaphane in broccoli membrane vesicles and their in vitro antiproliferative activity
por: Lucía Yepes-Molina, et al.
Publicado: (2021)

Immune complement activation is attenuated by surface nanotopography
por: Elwing H, et al.
Publicado: (2011)

Prognostic significance of pretreatment serum free fatty acid in patients with diffuse large B-cell lymphoma in the rituximab era: a retrospective analysis
por: Liping Fan, et al.
Publicado: (2021)

The immune system strikes back: cellular immune responses against indoleamine 2,3-dioxygenase.
por: Rikke Baek Sørensen, et al.
Publicado: (2009)

Chemo-photothermal therapy combination elicits anti-tumor immunity against advanced metastatic cancer
por: Jutaek Nam, et al.
Publicado: (2018)

Rituximab for refractory granulomatous eye disease
por: Lower EE, et al.
Publicado: (2012)

The potential effect of statins on rituximab immunotherapy.
por: Mark S Cragg
Publicado: (2008)

DNA-templated synthesis of biomimetic cell wall for nanoencapsulation and protection of mammalian cells
por: Peng Shi, et al.
Publicado: (2019)

Nanoencapsulation of the sasanquasaponin from Camellia oleifera, its photo responsiveness and neuroprotective effects
por: Ye Y, et al.
Publicado: (2014)

Concurrent type 1 diabetes mellitus and beta-cell lymphoma in a 12 year-old child: treatment with rituximab does not changethe clinical course of diabetes
por: Aleksey Vasil'evich Kiyaev, et al.
Publicado: (2009)

Complementary Roles of Short and Long Pentraxins in the Complement-Mediated Immune Response to Aspergillus fumigatus Infections
por: Raffaella Parente, et al.
Publicado: (2021)

Increased Production of Outer Membrane Vesicles by Salmonella Interferes with Complement-Mediated Innate Immune Attack
por: Ruchika Dehinwal, et al.
Publicado: (2021)

Cellular origins and genetic landscape of cutaneous gamma delta T cell lymphomas
por: Jay Daniels, et al.
Publicado: (2020)

COFUNCTIONING OF PROTECTIVE SYSTEMS: MUCOSAL IMMUNITY AND HUMAN COMPLEMENT SYSTEM
por: M. V. Lakhtin, et al.
Publicado: (2015)

Antibody-Dependent Cellular Cytotoxicity-Competent Antibodies against HIV-1-Infected Cells in Plasma from HIV-Infected Subjects
por: Franck P. Dupuy, et al.
Publicado: (2019)

Update on the use of rituximab for intractable rheumatoid arthritis
por: R John Looney
Publicado: (2009)

The evaluation and optimal use of rituximab in lymphoid malignancies
por: Smolewski P, et al.
Publicado: (2012)

Rituximab therapy in Greek patients with rheumatoid arthritis
por: Haralampos M Moutsopoulos, et al.
Publicado: (2008)

Correction: Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma
Publicado: (2021)

Cytokine and Complement Response in the Glaucomatous βB1-CTGF Mouse Model
por: Sabrina Reinehr, et al.
Publicado: (2021)

Pre-metastatic cancer exosomes induce immune surveillance by patrolling monocytes at the metastatic niche
por: Michael P. Plebanek, et al.
Publicado: (2017)

Correction: Publisher Correction: Smac mimetics synergize with immune checkpoint inhibitors to promote tumour immunity against glioblastoma
por: Shawn T. Beug, et al.
Publicado: (2018)

Author Correction: Loss of SNORA73 reprograms cellular metabolism and protects against steatohepatitis
por: Arthur C. Sletten, et al.
Publicado: (2021)